# Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER).

Study · id `cardio:ct-nct07055919` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07055919](<https://clinicaltrials.gov/study/NCT07055919>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07055919

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 112 participants.

## Technical summary

Registry record NCT07055919. Randomized; no masking; primary purpose treatment. Start 2025-03-22 (actual); primary completion 2026-03-22 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 112 participants (planned count; ClinicalTrials.gov record NCT07055919, source copy `cardio:ctgov-nct07055919-2025-07-09`, retrieved 2026-10-26)
- Started: 2025-03-22 (actual) (ClinicalTrials.gov record NCT07055919, source copy `cardio:ctgov-nct07055919-2025-07-09`, retrieved 2026-10-26)
- Primary completion: 2026-03-22 (anticipated) (ClinicalTrials.gov record NCT07055919, source copy `cardio:ctgov-nct07055919-2025-07-09`, retrieved 2026-10-26)
- Completion: 2026-04-22 (anticipated) (ClinicalTrials.gov record NCT07055919, source copy `cardio:ctgov-nct07055919-2025-07-09`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07055919, source copy `cardio:ctgov-nct07055919-2025-07-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07055919-2025-07-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER).
- Condition: Mitral R
- Condition: Mitral Regurgitation
- Intervention (Device): Structural Heart Surgery Assist System
- Intervention (Device): Manual MitraClip G4
- Lead sponsor: Xiamen Cardiovascular Hospital, Xiamen University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Xiamen Cardiovascular Hospital, Xiamen University (`cardio:org-xiamen-cardiovascular-hospital-xiamen-university`)

## Provenance

Content hash: eb88705fbf8d04358766b70c9c1002ac805cf7627e992c9a7dc7e862b8f8ca69
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
